(Q51565216)

English

Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands.

scientific article published on 5 December 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

0 references

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

Krzysztof Trzciński

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

object named as

Debby Bogaert

6

0 references

Elisabeth Sanders

8

object named as

Elisabeth A M Sanders

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

7

object named as

Nynke Y Rots

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

3

object named as

Jacob P Bruin

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

Marlies van Houten

2

object named as

Marlies A van Houten

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

Alienke J Wijmenga-Monsuur

4

object named as

Alienke J Wijmenga-Monsuur

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

1

object named as

Astrid A T M Bosch

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

language of work or name

0 references

publication date

5 December 2015

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

34

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

531-539

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

The fundamental link between pneumococcal carriage and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Using pneumococcal carriage data to monitor postvaccination changes in invasive disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Viral and bacterial interactions in the upper respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

The bacteriology of the nasopharynx in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Streptococcus pneumoniae colonisation: the key to pneumococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Pneumococcal capsular polysaccharide structure predicts serotype prevalence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Nasopharyngeal versus oropharyngeal sampling for detection of pneumococcal carriage in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

The increasing incidence of empyema

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

The pneumococcal pilus predicts the absence of Staphylococcus aureus co-colonization in pneumococcal carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Carriage of Haemophilus influenzae is associated with pneumococcal vaccination in Italian children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Effects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Lack of utility of serotyping multiple colonies for detection of simultaneous nasopharyngeal carriage of different pneumococcal serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Streptococcus pneumoniae in saliva of Dutch primary school children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Improved detection of nasopharyngeal cocolonization by multiple pneumococcal serotypes by use of latex agglutination or molecular serotyping by microarray

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Superiority of trans-oral over trans-nasal sampling in detecting Streptococcus pneumoniae colonization in adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Carriage of Streptococcus pneumoniae in aged adults with influenza-like-illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.11.060

7 January 2021

Identifiers

10.1016/J.VACCINE.2015.11.060

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/26667610

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51565216&oldid=1775319381"